UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000060549 |
|---|---|
| Receipt number | R000066119 |
| Scientific Title | Behavioral science studies to promote understanding of guideline-based cancer screening |
| Date of disclosure of the study information | 2026/02/03 |
| Last modified on | 2026/02/02 12:09:56 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study on ways to promote understanding of guideline-based cancer screening
Acronym
Study to disseminate guideline-based cancer screening
Scientific Title
Behavioral science studies to promote understanding of guideline-based cancer screening
Scientific Title:Acronym
Study to promote understanding of guideline-based cancer screening
Region
| Japan |
Condition
Condition
Stomach cancer, colon cancer, lung cancer, cervical cancer, breast cancer
Classification by specialty
| Medicine in general | Not applicable | Adult |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To examine what approaches are appropriate to advance the understanding of the benefits-disadvantages of cancer screening for ordinary employees.
Basic objectives2
Others
Basic objectives -Others
To compare the effectiveness of three video materials created by researchers with the goal of encouraging people to receive guideline-based cancer screenings.
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
In the questionnaire survey, after viewing the video, respondents were asked,"What kind of cancer screening would you like to receive?" Primary outcome is the number of respondents who choose "I want to be screened for cancer as recommended by the guidelines" and do not choose the screening options not based on the guidelines.
Key secondary outcomes
Relevance, clarity, informativeness, acceptability, aversiveness, perceived impact on discussions with family and friends, and perceived impact on intentions to receive guideline-based cancer screenings
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
YES
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
NO
Concealment
No need to know
Intervention
No. of arms
3
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
A science-based explanatory video detailing the potential harms of screening outside guideline recommendations, such as screening at a young age, overly frequent screening, and overdiagnosis
Interventions/Control_2
A narrative-style video depicting a realistic personal story of an individual adversely affected by inappropriate screening
Interventions/Control_3
An engaging, fast-paced dialogue-based video with humorous elements intended to attract viewer interest
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 60 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Individuals registered as panel members with a survey company (Rakuten Insight, Inc.)
Employed persons aged between 30 and 60 years
Those who provided informed consent to participate in the study
Key exclusion criteria
Individuals with a history of gastric, colorectal, lung, cervical, or breast cancer
Individuals who have undergone cancer screenings offered by local governments within the past three years
Target sample size
1200
Research contact person
Name of lead principal investigator
| 1st name | Masayuki |
| Middle name | |
| Last name | Tatemichi |
Organization
Tokai University School of Medicine
Division name
Department of Preventive Medicine
Zip code
2591193
Address
143 Shimokasuya, Isehara City, Kanagawa, Japan
TEL
0463931121
tatemichi@tokai.ac.jp
Public contact
Name of contact person
| 1st name | Kosuke |
| Middle name | |
| Last name | Sakai |
Organization
Tokai University School of Medicine
Division name
Department of Preventive Medicine
Zip code
2591193
Address
143 Shimokasuya, Isehara City, Kanagawa, Japan
TEL
0463931121
Homepage URL
ksakai@tokai.ac.jp
Sponsor or person
Institute
Tokai University
Institute
Department
Personal name
Funding Source
Organization
Ministry of Health, Labour and Welfare
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Research Ethics Committee, Tokai University School of Medicine
Address
143 Shimokasuya, Isehara City, Kanagawa, Japan
Tel
0463931121
tokai-rec@tokai.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 02 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
1200
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2025 | Year | 02 | Month | 01 | Day |
Date of IRB
| 2025 | Year | 02 | Month | 10 | Day |
Anticipated trial start date
| 2025 | Year | 06 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 06 | Month | 15 | Day |
Date of closure to data entry
| 2025 | Year | 06 | Month | 20 | Day |
Date trial data considered complete
| 2025 | Year | 06 | Month | 30 | Day |
Date analysis concluded
| 2025 | Year | 07 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2026 | Year | 02 | Month | 02 | Day |
Last modified on
| 2026 | Year | 02 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066119
